Every two minutes, a man is diagnosed with prostate cancer in our country. This disease is currently the second-leading cancer-related killer of men in the United States.

Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 109,000 ...

The Global Oncology Drug market was estimated at $227.2 billion in 2024 and is projected to reach $582.21 billion by 2034 , reflecting a robust CAGR of 11.67% over the forecast period from 2024 to ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

GenesisCare has launched its first self-referral mpMRI prostate cancer screening service at its Oxford outpatient centre.

Giles Coren, esteemed restaurant critic and writer, has come forward with his prostate cancer diagnosis amid a surge in ...

David James, director of patient projects and influencing at Prostate Cancer Research, has set the record straight on some of ...